The fetus may adapt to challenges in the intrauterine environment by slowing its metabolism and reducing its growth. In the short term, this strategy may be important for survival, but the adaptive responses could have longterm, adverse consequences that appear only decades later (1, 2) . Restricted growth, indicated by low birth weight, may represent an extreme form of adaptation, and many studies have shown an inverse association of birth weight with cardiovascular disease in adulthood (3) (4) (5) . However, adaptations to a suboptimal intrauterine environment may also occur without a noticeable reduction in birth weight and still be of long-term importance (6) (7) (8) .
The placenta is in a key position to mediate such environmental effects because adequate placental function is necessary for delivery of nutrients, oxygen, and hormones to the fetus (6, 7, 9) . Although placental weight alone may be a crude proxy for its function, placental size is correlated with birth size (7, 10, 11) , and the ratio between placental weight and birth weight could be a useful indicator for placental efficiency (7) . Thus, a comparatively large placenta relative to birth weight may be an expression of a relatively inefficient placenta with reduced ability to translate its own growth into fetal growth (7) . Both animal (12, 13) and human (2, 14) studies suggest that a placenta that is large relative to birth weight may be a marker for reduced nutrient supply to the fetus. A large US birth cohort study recently showed that a high placenta-to-birth-weight ratio, but not birth weight itself, was associated with high blood pressure in childhood (15) .
Although epidemiologic data indicate that placental weight may be associated with adult health (16) , it remains unknown whether indicators of placental function are associated with adult risk of cardiovascular death. We therefore assessed whether placental weight relative to birth weight is Correspondence to Dr. Kari R. Risnes, Department of Public Health, Medical Research Centre, NO-7489 Trondheim, Norway (e-mail: kari.risnes@ntnu.no).
positively associated with cardiovascular mortality in adulthood in a population of more than 31,000 men and women born between 1934 and 1959.
MATERIALS AND METHODS

Study cohort
This study was a cardiovascular mortality follow-up of a cohort of men and women born at St. Olav's University Hospital in Trondheim, Norway. We collected detailed information on birth measurements and maternal factors from archived individual birth charts that were systematically recorded at delivery.
On the charts, each child was registered by the mother's name, the child's birth date, and the child's given name. To ascertain the identity of the participants in adulthood, we depended on the 11-digit identification number allocated to all Norwegian citizens beginning in 1960 and the National Population Register that continuously updates vital status and residential history of all residents of the country.
Beginning in 1934, placental weight was recorded on the birth charts. Therefore, the eligible population was restricted to people who were born at St. Olav's Hospital from 1934 to 1959 and were alive and could be traced in 1960. Of 19,231 female offspring born at this hospital from 1934 to 1959, we reliably identified 15,666 (81%); of the 20,179 males, we reliably identified 18,536 (92%). Of the 34,202 eligible individuals, we excluded multiple births (n ¼ 706), preterm births (n ¼ 728), and 1,461 individuals for whom data on study variables were missing (missing placental weight (n ¼ 946), missing gestational age (n ¼ 300), and other missing factors (n ¼ 215)), leaving a total of 31,307 men and women for follow-up.
Follow-up
Individual follow-up information on deaths was available beginning in 1960, after the unique identification number was introduced. Therefore, participants in this study contributed follow-up time from January 1, 1961, until death from any cause, emigration, or the end of follow-up on December 31, 2005. Birth record data were linked to information from the Cause of Death Register at Statistics Norway, providing cause-specific information on cohort deaths that occurred during follow-up. This register contains electronically stored information mandatorily reported by physicians on standardized forms; to ensure completeness, the Cause of Death Register is cross-linked to updated vital status recorded by the National Population Register. Causes of death were categorized according to the International Classification of Diseases (ICD), Seventh-Tenth Revisions (accidents and injuries: ICD-7-9 codes 800-999, ICD-10 codes V01-Y89; cardiovascular disease: ICD-7 codes  330-334 and 420-468, ICD-8 codes 390-458, ICD-9 codes  390-459, ICD-10 codes I00-I99; coronary heart disease:  ICD-7 codes 420 and 422, ICD-8 and ICD-9 codes  410-414, ICD-10 codes I20-I25; and stroke: ICD-7  codes 330-334, ICD-8 and ICD-9 codes 430-438, ICD-10 codes I60-I69.)
Study variables
Information on placental weight (grams) and birth weight (grams) was abstracted from the birth charts. The placentato-birth-weight ratio was calculated as placental weight divided by birth weight and was multiplied by 100 to give the percentage of placental weight relative to birth weight. In the analysis of continuous variables, we used a standard deviation score for each variable. These scores were calculated by subtracting the mean value within each sex-and birth-cohort stratum (born before or after 1945) from the observed value and then dividing by the stratum-specific standard deviation. Each study variable (placenta-to-birthweight ratio, placental weight, and birth weight) was also divided into categories of approximate thirds according to sex and birth cohort (before or after 1945).
We also abstracted information on birth order, multiple births, and maternal factors including age (years) and marital status, as well as information on paternal occupation at the time of the child's birth (maternal occupation for single mothers). The birth chart included data on maternal height at childbearing (centimeters) for 29,347 (93.7%) of the participants. Length of gestation was calculated at birth on the basis of the first day or week of the last menstrual period and was recorded in completed weeks (n ¼ 13,789), or completed months (n ¼ 17,518) when information in weeks was not available. In the analysis, we defined as term delivery pregnancies of at least 37 weeks, or at least 8 months of completed gestation if information in weeks was not available. The charts contained information related to preeclampsia and hypertension. On the basis of the information available before 1945, we defined preeclampsia as recorded albuminuria or generalized edemas with oliguria or, alternatively, as eclampsia. Information on blood pressure was not available from birth charts before 1945. Beginning in 1945, preeclampsia was defined as the presence of albuminuria (>2& by Esbach's test) and hypertension (>150/95 mm Hg), as recorded on the birth charts.
For 19,936 (63.7%) study participants, we obtained information on adult height and weight from previous surveys conducted by the National Health Screening Service of Norway in the 1960s and 1970s. (17) . We calculated body mass index (BMI) in adulthood as weight (in kilograms) divided by the squared value of height (in meters). In the analyses in which adult BMI was included, mortality followup started on the date that this information was collected.
Statistical analysis
We used the Cox proportional hazards model to calculate hazard ratios of death from accidents and injuries, total cardiovascular disease, and, specifically, coronary heart disease and stroke associated with standard deviation scores and categories (thirds) of the placenta-to-birth-weight ratio, birth weight, and placental weight. In the analysis of categories (thirds), the lowest third of each variable was used as the reference; to test for trend across categories, we treated each factor (in thirds) as a continuous variable. Precision of the estimates was assessed by 95% confidence intervals. We used linear regression analyses to test whether maternal factors (maternal age and maternal height), gestational age, or adult BMI was associated with standard deviation differences in birth weight, placental weight, and the placenta-tobirth-weight ratio.
Our basic Cox regression analyses were age adjusted by using attained age as the time variable. To adjust for possible cohort effects, we included birth year before or after 1945 in the regression model. We tested for effect modification by sex by including a product term between sex and each birth size measure in the regression model, and we tested for nonlinear associations by including a quadratic term for each birth measure (standard deviation score) in the regression model, using a likelihood ratio test. In a complementary multivariable analysis, we also adjusted for maternal age at childbearing (years), birth order (first, second, and third or higher), paternal occupation (manual labor vs. other), maternal marital status (married, unmarried), gestational age (months), and preeclampsia or hypertension in pregnancy (yes, no). In separate analyses, we also adjusted for maternal height (thirds) and adult BMI (thirds).
For this study, birth weight was included as a covariate in the analysis of placental weight. The ratio between placental weight and birth weight may be regarded as an interaction term for the 2 variables. Therefore, we included birth weight and placental weight in the same statistical model, and we tested for interaction between the 2 variables using a likelihood ratio test. Sensitivity analyses were performed by comparing mortality rates of cardiovascular disease for people with and without information on placental weight among those eligible for follow-up.
All statistical tests were 2-sided. All analyses were performed by using Stata for Windows software (version 10, ; StataCorp LP, College Station, Texas).
This study was approved by the Norwegian Data Inspectorate, the Norwegian Board of Health, and the Regional Committee for Ethics in Medical Research.
RESULTS
During 45 years of follow-up of 31,307 men and women, 1,818 of them died. Of these deaths, 438 were from accidents and injuries and 382 were due to cardiovascular causes, including 232 from coronary heart disease and 64 from stroke. Median age at death from all cardiovascular causes was 51.3 years, and median age at death from stroke was 50.5 years, reflecting the relatively young age of this population.
Basic characteristics of the study population, by thirds of the placenta-to-birth-weight ratio, are shown in Table 1 . Whereas placental weight increased across categories, there was a slight reduction in birth weight. Thus, mean placental weight was 32% higher in the highest compared with the lowest third, and birth weight was 5% lower in the highest third. Maternal age, maternal height, and gestational age were inversely associated with the placenta-to-birth-weight ratio. In addition, this ratio was negatively associated with No. of deaths from stroke 13 22 29 a According to sex and birth cohort (1934) (1935) (1936) (1937) (1938) (1939) (1940) (1941) (1942) (1943) (1944) (1945) (1946) (1947) (1948) (1949) (1950) (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) (1959) adult BMI, whereas placental weight and birth weight were positively associated with adult BMI (all P < 0.005). Table 2 shows hazard ratios of deaths from cardiovascular causes, including coronary heart disease and stroke, associated with standard deviation scores of birth weight, placental weight, and the placenta-to-birth-weight ratio. For comparison, the associations of birth size measures with deaths from accidents and injuries are also shown, but we found no evidence of any association. In addition, there was no evidence of nonlinear associations. Because there was no indication of interaction by sex for any of the exposure variables (all P > 0.52), we combined the data for men and women in the analyses and included sex as a covariable. Birth weight was negatively associated with cardiovascular deaths: a 1-standarddeviation increase in birth weight (470 g) was associated with approximately a 15% lower risk of cardiovascular death. The placenta-to-birth-weight ratio was positively associated with cardiovascular deaths: a 1-standard-deviation increase was associated with approximately a 15% higher risk of death from cardiovascular causes. The association of placental weight with cardiovascular deaths was similar to the associations observed for the placenta-to-birth-weight ratio. The hazard ratio per standard deviation increase in placental weight, after adjustment for birth weight, sex, and cohort, was 1.14 (95% confidence interval: 1.00, 1.28).
In a sensitivity analysis, cardiovascular mortality did not differ among people without information on placental weight and people with this information. The main analyses (Table 2) were adjusted for maternal age, birth order, maternal marital status, paternal occupation, and preeclampsia and hypertension in pregnancy, but including these variables did not substantially influence the estimated hazard ratios, and they were omitted from subsequent analyses.
In subsequent analysis, we assessed the associations of categories (thirds) of the placenta-to-birth-weight ratio, placental weight, and birth weight with deaths from cardiovascular disease (Table 3) , including coronary heart disease ( Table 4 ) and stroke ( Table 5 ). The hazard ratio of cardiovascular death associated with the highest compared with the lowest third of the placenta-to-birth-weight ratio was 1.38 (95% confidence interval: 1.07, 1.77). For coronary heart disease, the associations were quite similar to those observed for total cardiovascular mortality, but lower numbers of deaths yielded lower precision of the estimates. For stroke mortality, the sex-and cohort-adjusted hazard ratio for people in the highest compared with the lowest third of the placenta-to-birth-weight ratio was 2.11 (95% confidence interval: 1.10, 4.06).
We also tested for interaction between placental weight and birth weight (continuous). Results suggested that (1934) (1935) (1936) (1937) (1938) (1939) (1940) (1941) (1942) (1943) (1944) (1945) (1946) (1947) (1948) (1949) (1950) (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) (1959) ; placental weight was also adjusted for birth weight (continuous). c Adjusted for sex, birth cohort (1934) (1935) (1936) (1937) (1938) (1939) (1940) (1941) (1942) (1943) (1944) (1945) (1946) (1947) (1948) (1949) (1950) (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) (1959) , maternal marital status (married, unmarried), maternal age (years), birth order (1, 2, 3), preeclampsia or hypertension in pregnancy (yes, no), gestational age (months completed), and paternal occupation (manual, nonmanual); placental weight was also adjusted for birth weight (continuous).
d Adjusted for birth cohort (1934) (1935) (1936) (1937) (1938) (1939) (1940) (1941) (1942) (1943) (1944) (1945) (1946) (1947) (1948) (1949) (1950) (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) (1959) ; placental weight was also adjusted for birth weight (continuous). e Mean SD across birth cohort and sex.
the effect of placental weight may vary by birth weight (P interaction ¼ 0.001) (Table 6 ). Thus, for the lowest third of birth weight, the adjusted hazard ratio per standard deviation increase in placental weight was 1.04 (95% confidence interval: 0.86, 1.25); for the highest third of birth weight, the corresponding hazard ratio per standard deviation increase was 1.23 (95% confidence interval: 0.99, 1.53). In a supplementary analysis, we included maternal height as a covariate, but doing so did not influence the estimated associations (Table 7 ). In the analysis with information on adult BMI (195 cardiovascular deaths), the results were less precise, but the estimates of effect were not substantially different from those obtained from the main analyses (Table 8) .
DISCUSSION
In this population study, we found that the placenta-tobirth-weight ratio was positively associated with risk of death from cardiovascular causes and that the positive association was particularly strong for stroke. In addition, placental weight displayed a positive association with cardiovascular death after adjustment for birth weight.
In previous studies, associations with cardiovascular disease related to placental factors were not assessed in detail. Although the magnitude and precision of results were not fully reported, previous findings seem mainly to agree with ours (16) . Thus, reports from 2 birth cohort studies that included individuals born before the 1930s-the Helsinki, Finland, cohort (18, 19) and a cohort of men born in Sheffield, United Kingdom (20, 21)-suggested that high placental weight relative to birth weight could be associated with higher risk of cardiovascular death. The results that we observed for stroke, however, differ from those of other studies (19, 20) . Whereas we found a strong, positive association of the placenta-to-birth-weight ratio with deaths from stroke, others have reported a U-shaped (19, 20) or even an inverse (20) association. The inverse association of birth weight with deaths from coronary heart disease that we found agrees with others' evidence (3). To our knowledge, 5 studies have previously assessed the association of birth weight with stroke (5, 20, (22) (23) (24) , and all reported inverse associations. Although the precision of the estimates related to stroke was modest in our study, our findings suggest that the estimated size of the effect may be larger than that reported for coronary heart disease. A similar observation was made in a cohort study of people born in Aberdeen, United Kingdom, in the 1950s (5).
Our study participants represent all institutional births that took place in a defined geographic region of Norway between 1934 and 1959. The cohort is likely to be representative of the general population since the proportion of births in this institution increased from approximately 75% of all births in 1934 to more than 90% after 1944. Some individuals could not be reliably identified, and linkage between mother and child could not always be verified, especially for women whose last names had changed through marriage or if the mother had died before the unique identification number was introduced in 1960. However, it seems unlikely that the association of placental size with adult risk of cardiovascular death differed between people who were traced and those who were not.
It is a strong feature of our study that all measures of birth size and placental weight were standardized and systematically recorded in the birth charts; the placenta was weighed fresh and untrimmed. It could be argued that placental weight is not a highly reliable measure because it is influenced by factors such as mode of delivery, time to cord clamping, and length of pregnancy (25) . However, it is reassuring that a study based on more than 200,000 deliveries reported to the Medical Birth Registry of Norway (26) showed a distribution of the relation between placental weight and birth weight similar to what we observed in our study. Moreover, our study had a prospective design, and inaccuracy in the measurements of placental weight cannot be related to outcomes in adulthood. If anything, the observed associations with cardiovascular death are therefore likely to be conservatively estimated.
The inconsistent information on gestational age may be a weakness of our study, since the placenta-to-birth-weight ratio is influenced by length of gestation. However, although gestational age was associated with the placenta-to-birthweight ratio in these data, including it in the Cox regression model did not affect the estimated associations. Compared with previous studies, ours had more comprehensive information on maternal factors and pregnancy complications. To our knowledge, no previous study has included information on preeclampsia and pregnancy hypertension or maternal height. However, we did not have information on maternal weight, a factor that could have a potentially confounding effect. In addition, maternal diabetes could be a potential confounder, but information in the birth charts indicates that maternal diabetes was extremely rare in this cohort and therefore was not likely to be an important confounding factor in these data. Information on maternal smoking was not complete in our study, but smoking by women was rare in Norway before 1955 (27) and is unlikely to have substantially influenced our results. One previous study was able to adjust for maternal smoking (24) , as well as cardiovascular risk factors in adult life, but this adjustment did not influence the association of birth size with adult heart disease and stroke. Although information on cause-specific mortality from the National Cause of Death Register is based on mandatory death reports from physicians who have examined the patient, there may be discrepancies between causes of death based on clinical judgment and autopsy findings (28) . However, information on perinatal factors and mortality was independently collected, and a possible misclassification of deaths could not be influenced by information collected from the birth charts.
The higher cardiovascular mortality associated with a relatively large placenta may be attributed to either the baby being disproportionately small or the placenta being disproportionately large. Thus, it is possible that fetal factors (29), such as malformations or genetic factors, could inhibit fetal growth, independent of placental function, and be positively associated with long-term risk of cardiovascular death. However, in our data, it was the increase in placental weight that distinguished the categories of the placenta-to-birthweight ratio, not the variation in birth weight. After adjustment for birth weight, placental weight was also positively associated with cardiovascular mortality. These findings may support the interpretation that a relatively large placenta is associated with higher risk of cardiovascular disease.
As the placenta increases relative to fetal size, the placental disc increases in thickness, presumably beyond the optimal (7). These changes are likely to increase fetal energy expenditure and vascular resistance (7) and lead to higher fetal cardiovascular workload (9) , which may disturb growth and maturation of fetal cardiomyocytes and limit capillary formation in myocardium, thereby increasing vulnerability to cardiac ischemia (30, 31) . The twin-to-twin transfusion syndrome is a clinical situation illustrating that increased placental vascularization has direct, adverse consequences on the fetal cardiovascular system. In this situation, there is an imbalance in blood flow due to inter-twin anastomoses in the placenta. At birth, the recipient is large and has high-output cardiac failure and hypertension (32) .
It has been shown that reduced nutritional supply to the fetus may lead to compensatory growth of the placenta, without noticeable restriction of fetal growth (2, (12) (13) (14) . It is also known that maternal factors such as overweight, gestational diabetes, and suboptimal oxygen delivery are associated with relatively large placentas and a high placenta-to-birth-weight ratio (10, (33) (34) (35) (36) (37) . The thick placenta may reduce efficiency because of increased villous depth. Blood perfusion of abnormally thick placentas is thought to be less efficient, and the oxygen demands required to maintain a large placenta may limit oxygen and nutrient availability to the fetus (36) , causing the fetus to be growth restricted relative to the placenta.
We conclude that the positive association of the placentato-birth-weight ratio with cardiovascular mortality may be attributed to the consequences of a relatively growthrestricted fetus or to a disproportionately large placenta, which may impose an increased cardiovascular burden on the fetus. This finding may be central to advancing our understanding of how intrauterine factors influence the risk of cardiovascular disease later in life. 
